FI924457A0 - Kompositioner och behandlingsfoerfarande foer lunginflammation i djur - Google Patents
Kompositioner och behandlingsfoerfarande foer lunginflammation i djurInfo
- Publication number
- FI924457A0 FI924457A0 FI924457A FI924457A FI924457A0 FI 924457 A0 FI924457 A0 FI 924457A0 FI 924457 A FI924457 A FI 924457A FI 924457 A FI924457 A FI 924457A FI 924457 A0 FI924457 A0 FI 924457A0
- Authority
- FI
- Finland
- Prior art keywords
- haemolytica
- lunginflammation
- behandlingsfoerfarande
- djur
- foer
- Prior art date
Links
- 206010035664 Pneumonia Diseases 0.000 title abstract 3
- 241001293418 Mannheimia haemolytica Species 0.000 abstract 5
- 239000000427 antigen Substances 0.000 abstract 4
- 102000036639 antigens Human genes 0.000 abstract 4
- 108091007433 antigens Proteins 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- FBUKMFOXMZRGRB-UHFFFAOYSA-N Coronaric acid Natural products CCCCCC=CCC1OC1CCCCCCCC(O)=O FBUKMFOXMZRGRB-UHFFFAOYSA-N 0.000 abstract 1
- 101710177917 Fimbrial protein Proteins 0.000 abstract 1
- 101710170970 Leukotoxin Proteins 0.000 abstract 1
- 101710116435 Outer membrane protein Proteins 0.000 abstract 1
- 208000008939 Pneumonic Pasteurellosis Diseases 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50485090A | 1990-04-05 | 1990-04-05 | |
| PCT/CA1990/000170 WO1991015237A1 (en) | 1990-04-05 | 1990-05-25 | Compositions and treatments for pneumonia in animals |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI924457A0 true FI924457A0 (fi) | 1992-10-02 |
| FI924457A FI924457A (fi) | 1992-10-02 |
Family
ID=24008001
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI924457A FI924457A (fi) | 1990-04-05 | 1992-10-02 | Kompositioner och behandlingsfoerfarande foer lunginflammation i djur |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0527724B1 (fi) |
| JP (1) | JPH05508301A (fi) |
| AT (1) | ATE157258T1 (fi) |
| AU (1) | AU642650B2 (fi) |
| DE (1) | DE69031351T2 (fi) |
| ES (1) | ES2108693T3 (fi) |
| FI (1) | FI924457A (fi) |
| WO (1) | WO1991015237A1 (fi) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5849531A (en) * | 1989-04-07 | 1998-12-15 | University Of Saskatchewan | Compositions and treatments for pneumonia in animals |
| CA2014033C (en) * | 1989-04-07 | 1993-02-09 | Stephen D. Acres | Compositions and treatments for pneumonia in animals |
| US6797272B1 (en) | 1991-10-16 | 2004-09-28 | University Of Saskatchewan | Enhanced immunogenicity using leukotoxin chimeras |
| US5837268A (en) * | 1991-10-16 | 1998-11-17 | University Of Saskatchewan | GnRH-leukotoxin chimeras |
| US5723129A (en) * | 1991-10-16 | 1998-03-03 | University Of Saskatchewan | GnRH-leukotoxin chimeras |
| AU2699192A (en) * | 1991-10-16 | 1993-05-21 | University Of Saskatchewan | Enhanced immunogenicity using leukotoxin chimeras |
| US5422110A (en) * | 1991-10-16 | 1995-06-06 | University Of Saskatchewan | Enhanced immunogenicity using leukotoxin chimeras |
| MX9301736A (es) * | 1992-03-30 | 1994-01-31 | Smithkline Beecham Corp | Vacuna de bacterina-toxoide de pasteurella haemolytica tipo a-1. |
| US5855894A (en) * | 1992-03-30 | 1999-01-05 | Pfizer Inc. | Pasteurella haemolytica type A-1 bacterin-toxoid vaccine |
| US5534256A (en) * | 1992-07-02 | 1996-07-09 | University Of Saskatchewan | Haemophilus somnus outer membrane protein extract enriched with iron-regulated proteins |
| US5441736A (en) * | 1992-11-05 | 1995-08-15 | University Of Saskatchewan | Actinobacillus pleuropneumoniae outer membrane lipoprotein A and uses thereof |
| EP0751956A1 (en) * | 1994-03-22 | 1997-01-08 | Pfizer Inc. | $i(PASTEURELLACEAE) ANTIGENS AND RELATED VACCINES |
| US6903184B1 (en) | 1998-03-02 | 2005-06-07 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Multiple antigenic peptides immunogenic against Streptococcus pneumonia |
| AU758764B2 (en) * | 1998-03-02 | 2003-03-27 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Epitope peptides immunogenic against (streptococcus pneumoniae) |
| US20100330158A1 (en) * | 2009-03-31 | 2010-12-30 | Innopharma, Llc | Protein-assisted drug delivery system for the targeted administration of active agents |
| AU2010234193B2 (en) * | 2009-04-06 | 2015-08-20 | University Of Saskatchewan | Methods and compositions for treating and preventing Shiga toxin-producing Escherichia coli infection |
-
1990
- 1990-05-25 DE DE69031351T patent/DE69031351T2/de not_active Expired - Lifetime
- 1990-05-25 AT AT90906831T patent/ATE157258T1/de not_active IP Right Cessation
- 1990-05-25 ES ES90906831T patent/ES2108693T3/es not_active Expired - Lifetime
- 1990-05-25 EP EP90906831A patent/EP0527724B1/en not_active Expired - Lifetime
- 1990-05-25 WO PCT/CA1990/000170 patent/WO1991015237A1/en active IP Right Grant
- 1990-05-25 AU AU56621/90A patent/AU642650B2/en not_active Expired
- 1990-05-25 JP JP2507689A patent/JPH05508301A/ja active Pending
-
1992
- 1992-10-02 FI FI924457A patent/FI924457A/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2108693T3 (es) | 1998-01-01 |
| DE69031351D1 (de) | 1997-10-02 |
| ATE157258T1 (de) | 1997-09-15 |
| EP0527724B1 (en) | 1997-08-27 |
| AU5662190A (en) | 1991-10-30 |
| WO1991015237A1 (en) | 1991-10-17 |
| DE69031351T2 (de) | 1998-02-05 |
| AU642650B2 (en) | 1993-10-28 |
| EP0527724A1 (en) | 1993-02-24 |
| JPH05508301A (ja) | 1993-11-25 |
| FI924457A (fi) | 1992-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2014033A1 (en) | Compositions and treatments for pneumonia in animals | |
| FI924457A0 (fi) | Kompositioner och behandlingsfoerfarande foer lunginflammation i djur | |
| ES2063965T3 (es) | Vacunas para haemophilus influenzae no tipificable. | |
| DE68921895D1 (de) | Meningococcales klasse i-aussenmembranprotein-vakzin. | |
| ATE127345T1 (de) | Stressproteine und verwendungen dafür. | |
| KR890701770A (ko) | 호흡성 신시아 비루스 : 백신 및 진단검사법 | |
| NZ512574A (en) | Novel streptococcus antigens useful as vaccines | |
| DK0612250T3 (da) | Fremgangsmåder og præparater med relation til nyttige Moraxella catarrhalis-antigener | |
| DE3886506D1 (de) | Avirulente mikroben und deren verwendungen. | |
| FI102382B1 (fi) | Ilmentämisjärjestelmä ihmisen respiratory syncytial -viruksen glykoproteiinien immunogeenisia fragmentteja sisältäviä kimeerisiä glykoproteiineja varten | |
| KR890701758A (ko) | 재조합 dna에서 유도한 보르데텔라 외독소 소단위체의 유사체 및 그를 포함하는 백신 | |
| ATE120487T1 (de) | Therapeutische zusammensetzungen gegen streptokokken-infektionen, transformierte wirte, verfahren zur immunisierung und gentechnologisch hergestellte produkte. | |
| DE69228944D1 (de) | Bovines herpesvirus typ 1rekombinantenpolypeptide und vakzine | |
| FI902569A0 (fi) | Producering av till gonorre anslutande pi-proteiner och vaccin. | |
| DE68915046D1 (de) | Haemophilus influenzae Typ B Polysaccharid-Aussermembranprotein-Konjugat als Impfstoff. | |
| KR890006253A (ko) | 가금류내의 E.coli septicaemia에 대한 백신 | |
| ES2079851T3 (es) | Uso de il-4 para mejorar la respuesta inmunitaria frente a inmunogenos en vacunas. | |
| DK76191A (da) | Filamentoest haemagglutinin fra b.pertussis | |
| BR9306187A (pt) | Vacina bacterin-toxóide pasteurella haemolytica tipo a-1 | |
| ZA888580B (en) | New immunologically active synthetic peptides useful for preparing an antimalarial vaccine | |
| ATE145335T1 (de) | Kreuzreaktive immunisierung gegen influenza | |
| Potter | Pasteurella haemolytica leukotoxin compositions and uses thereof | |
| GB2314560A (en) | Synthetic peptides of m. gallisepticum, antibodies thereto, their preparations and use | |
| ATE305941T1 (de) | Impfstoff | |
| CVI | Crossed immunoelectrophoresis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |